SYRE – spyre therapeutics, inc. (US:NASDAQ)

News

Spyre Therapeutics Announces Grants of Inducement Awards
Hot Picks: Biotech sector draws investor attention ahead of key data [BNN Bloomberg (Canada)]
Spyre Therapeutics Announces Grants of Inducement Awards
Spyre Therapeutics (SYRE) Valuation Check After Strong Recent Share Price Performance [Yahoo! Finance]
Spyre Therapeutics (NASDAQ:SYRE) had its "buy" rating reaffirmed by analysts at BTIG Research. They now have a $70.00 price target on the stock.
Show more
Live Event: Join our next subscriber-only event: "The Data Driven Investor"
Register for our next upcoming LIVE training session, which will be hosted on Tuesday April 24th at 08:00 PM EST (New York Time).
Get your questions answered during the Q & A session.
For any support questions, contact our team: support@newsquantified.com